Insurance Companies

Why is this important for
Insurance Companies?

DVT is an increasing condition that affects as many as 900,000 people (1 to 2 per 1,000) each year min the United States. Estimates suggest that 60,000 – 100,000 Americans die of DVT/PE each year.

  1. 10 to 30% of people will die within one month of diagnosis
  2. Sudden death is the first symptom in about 25% of people who have a PE

Among people who have had a DVT, one-half will have long-term complications (post-thrombotic syndrome) such as swelling, pain, discoloration, and scaling in the affected limb.

Need for Prevention at Home

Many factors determine your risk for DVT, but studies show you’re at highest risk five to 10 days after surgery.2 With today’s shorter hospital stays, that’s most likely when you’re recovering at home, away from the watchful eye of your health care providers. Therefore, it’s vital that life-saving DVT prevention doesn’t end at the time of discharge after surgery — but continues at home throughout your most vulnerable days. Your physician can prescribe DVT prevention that you can use at home, including both mechanical and pharmacological prophylaxis.

Hospital Re-admissions

When a patient must be readmitted to the hospital because of post-surgical DVT, the results can be devastating for everyone involved. Fact is, nearly 50 percent of all DVT cases happen after a patient is discharged.5 Triple Play VT® reduces this risk to patients — and their providers — by decreasing the likelihood of life-threatening, post-surgical DVT during the vulnerable first week after discharge. Designed to promote the continuum of care from the hospital to home after surgery, Triple Play VT is compact, portable and easy for patients to use. The result is greater compliance, positive patient experiences and better outcomes.

Never Events

Medical errors that should not happen are called “never events.” They not only harm patients, but hospitals as well, resulting in costly fines or loss of reimbursement. The Centers for Medicare & Medicaid Services have deemed DVT a never event. Still, DVT is the leading cause of preventable hospital deaths.6 Research shows one in 100 patients admitted to a hospital dies because of pulmonary embolism (PE), which is a result of DVT.7 Hospitals and surgical centers can affordably prevent life-threatening DVT never events with Triple Play VT®from Compression Solutions. Using DVT prophylaxis will reduce the incidence of DVT never events during the post-operative period by two-thirds and will prevent death from PE in one patient out of every 200 major operations.

Cost to Prevent vs. Treat

As with most other diseases, preventing DVT is substantially less expensive than treating its consequences. The cost to diagnose and treat DVT and its effects in the United States is estimated to be as much as $23.8 billion per year.9 According to the Centers for Medicare & Medicaid Services (CMS), DVT treatment costs an average of $50,937 per patient.

  • Aetna

    Giving Back

    Enfoque Ciudad Orphanage

    The PMP corporate cause is currently an Orphanage in Guadalajara Mexico. We believe in giving back and giving back in a BIG way. In the last 3 years, the Precision family has donated $167,000 to Enfoque de Ciudad Orphanage.

    Giving Back